MinervaX is pursuing the development of a maternal vaccine for the prevention of adverse pregnancy outcomes and life-threating infections caused by Group B streptococcus (GBS). The vaccine is based on adjuvanted proteins antigens covering close to 100% of clinical GBS isolates.

Group B Streptococcal (GBS) is the leading cause of life-threatening infections in newborns.  Colonization of pregnant women with GBS may lead to adverse pregnancy outcomes such as late abortions, stillbirths, and preterm delivery.  Colonization may also lead to life-threatening infections in newborns for the first 3 months of life, causing pneumonia, septicemia and meningitis, which may lead to death or life-long disability.

Annually, GBS is responsible for some 320,000 cases of neonatal invasive disease, 60,000 stillbirths, 3,500,000 preterm deliveries, and 10,000 babies suffering from long-term neurological damage world-wide.


Minervax ApS

MinervaX is highlighted as one of six top companies at the forefront of the antibiotic resistance field 😀 

https://lnkd.in/dNicpRJN


Proud to share the news that MinervaX won Entrepreneur of the Year 2023 in the Life Science Category last night.

MinervaX Raises EUR 54M in Upsized Financing to Advance the Development of its Maternal Vaccine Against Group B Streptococcus 


Listen today to Chief Executive Officer, @Per Fischer as he discusses the Global Burden of Group B Streptococcus and @Minervax ApS's focus as it aims to address the issue with its novel, prophylactic GBS vaccine with Editor in Chief @Jim Cornall on @labiotech.eu's weekly 'Beyond Biotech' podcast.

Full podcast available below

#MinervaX has developed a novel, clinical #GBS pipeline which has the potential to reduce deaths associated with GBS across the population as it continues to tackle the urgent unmet medical need, worldwide. 

Learn more about MinervaX on www.minervax.com and its ongoing clinical trials.

#Biotech #maternalvaccine #adjuventedproteinsantigens #neonatalinvasivedisease #GroupBStreptococcus

Pfizer is a multinational pharmaceutical company that is actively involved in vaccine development, including GBS vaccines.

Pfizer Inc.

GlaxoSmithKline is a global healthcare company with a focus on pharmaceuticals, vaccines, and consumer healthcare products.

GlaxoSmithKline

Sanofi is a multinational pharmaceutical company that has a strong presence in vaccine development and research.

Sanofi

MinervaX is a biotechnology company focused on developing vaccines for infectious diseases. The company's lead candidate is a vaccine designed to prevent Group B Streptococcus (GBS) infections, which are a major cause of neonatal and maternal infections.

MinervaX

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	May 16, 2024 6:04 AM	527bc5f4
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general
crunchbase trigger	general	Nov 18, 2024 2:12 PM	38679635
crunchbase profile	general
li profile	general	May 16, 2024 6:04 AM	8d3e97e6
translate crunchbase fundingrounds	general
peers	general
news basic	general
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

COM:MINERVAX

MinervaX